Neolife Financial Statements From 2010 to 2024

ALNLF Stock  EUR 0.06  0.0009  1.60%   
Neolife SA financial statements provide useful quarterly and yearly information to potential Neolife SA investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Neolife SA financial statements helps investors assess Neolife SA's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Neolife SA's valuation are summarized below:
Neolife SA does not presently have any fundamental ratios for analysis.
Check Neolife SA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Neolife SA's main balance sheet or income statement drivers, such as , as well as many indicators such as . Neolife financial statements analysis is a perfect complement when working with Neolife SA Valuation or Volatility modules.
  
This module can also supplement various Neolife SA Technical models . Check out the analysis of Neolife SA Correlation against competitors.

Neolife SA Company Current Valuation Analysis

Neolife SA's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Neolife SA Current Valuation

    
  3.6 M  
Most of Neolife SA's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Neolife SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Neolife SA has a Current Valuation of 3.6 M. This is 99.98% lower than that of the Professional Services sector and 99.84% lower than that of the Industrials industry. The current valuation for all France stocks is 99.98% higher than that of the company.

Neolife SA Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Neolife SA's current stock value. Our valuation model uses many indicators to compare Neolife SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Neolife SA competition to find correlations between indicators driving Neolife SA's intrinsic value. More Info.
Neolife SA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Neolife SA's earnings, one of the primary drivers of an investment's value.

About Neolife SA Financial Statements

Neolife SA shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Neolife SA investors may analyze each financial statement separately, they are all interrelated. The changes in Neolife SA's assets and liabilities, for example, are also reflected in the revenues and expenses on on Neolife SA's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Its solutions enable architects, landscapists, design offices, and building technicians to meet environmental specification packages for HQE , BREEAM, and LEED projects for individual and multi-unit housing, commercial buildings, and urban spaces. The company was incorporated in 2012 and is headquartered in Limonest, France. Neolife SA is traded on Paris Stock Exchange in France.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Neolife Stock Analysis

When running Neolife SA's price analysis, check to measure Neolife SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neolife SA is operating at the current time. Most of Neolife SA's value examination focuses on studying past and present price action to predict the probability of Neolife SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neolife SA's price. Additionally, you may evaluate how the addition of Neolife SA to your portfolios can decrease your overall portfolio volatility.